Name: Aytu BioPharma, Inc. (AYTU) Financial Statements
Creator: FinSpry

Aytu BioPharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Aytu BioPharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2019	Jun 2018
Revenue & Gross Profit
Revenue	66.38	65.18	107.40	96.67	65.63	7.32	3.66
Cost of Revenue	20.55	16.13	40.77	44.39	36.43	2.20	2.05
Gross Profit	45.83	49.05	66.63	52.28	29.20	5.12	1.61
Operating Expenses
Research & Development	1.33	2.77	4.10	12.66	42.06	0.59	0.17
Selling, General & Administrative	38.29	42.04	70.08	69.88	55.81	19.24	17.73
Operating Expenses	53.66	48.49	78.96	88.39	88.07	21.96	19.45
Operating Income	-7.83	0.57	-12.33	-36.10	-58.87	-16.85	-17.84
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	3.70	-5.06	4.96	-0.01	-0.01	0.00	0.75
Other Income/Expense	-5.92	-3.13	0.24	-72.79	-0.84	-10.29	7.66
Income
Income Before Tax	-13.75	-10.38	-17.05	-108.89	-58.03	-27.13	-10.19
Income Tax Expense	0.44	2.14	0.26	-0.11	0.26	0.00	0.00
Net Income	-13.56	-15.84	-17.05	-108.78	-58.29	-27.13	-10.19
Net Income - Continuous Operations	-13.56	-12.52	-17.05	-108.78	0.00	0.00	0.00
Net Income - Discontinued Operations	0.62	-3.32	0.00	0.00	0.00	0.00	0.00
EBITDA	-4.67	7.29	-3.27	-25.96	-29.04	-14.12	-15.25
EBIT	-10.04	0.57	-12.09	-36.10	-38.24	-16.85	-17.84
Depreciation & Amortization	5.38	6.73	4.79	5.84	6.01	2.14	1.55
Earnings Per Share
Basic EPS	-2.00	-3.00	-5.00	-75.00	-70.00	-35.00	-153.00
Diluted EPS	-2.00	-3.00	-5.00	-75.00	-70.00	-35.00	-153.00
Basic Shares Outstanding	6.28	5.54	3.34	1.47	0.84	0.78	0.07
Diluted Shares Outstanding	6.28	5.54	3.34	1.47	0.84	0.78	0.07